CT
Colleen Tupper
EVP & Chief Financial Officer

Colleen Tupper insider trades: Collegium Pharmaceutical (COLL) stock sales

EVP & Chief Financial Officer, Collegium Pharmaceutical Last trade Nov 6, 2025 14 Form 4 filings
$1.2M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2022
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Colleen reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 6, 2025COLL↓ Sell$1.2M
Mar 21, 2025COLL↓ Sell$228K
Mar 14, 2025COLL↓ Sell$29K
Mar 11, 2025COLL↓ Sell$313K
Mar 7, 2025COLL↓ Sell$104K
May 28, 2024COLL↓ Sell$674K
Mar 15, 2023COLL↓ Sell$752K
Oct 4, 2022COLL↓ Sell$75K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other COLL insiders

Open-market trades in the last 12 months

About Colleen Tupper's insider trades

Colleen Tupper is EVP & Chief Financial Officer at Collegium Pharmaceutical (COLL). Since Oct 4, 2022, Colleen has reported no open-market purchases and 8 sales worth $3.4M on SEC Form 4. In the last 12 months: 1 sale ($1.2M).

Their filings also include grants and awards (6 filings), shares withheld for taxes (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every COLL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.